Skip to main content
. 2023 Mar 17;227(Suppl 1):S3–S15. doi: 10.1093/infdis/jiac370

Figure 2.

Figure 2.

Virologic, immunologic and neuropathologic biomarkers that may be informative for biotype analyses. This subset includes biomarkers that vary greatly across pathologic states associated with untreated and/or treated infection. The utility of these biomakers is difficult to assess due to a lack of relevant data and/or nonstandardized data collection.